Cyril T Namba-Nzanguim
Publication Activity (10 Years)
Years Active: 2023-2024
Publications (10 Years): 6
Publications (10 Years): 6
Publications
- Donatus Bekindaka Eni, Joel A Cassel, Cyril T Namba-Nzanguim, Conrad V Simoben, Ian Tietjen, Ravikumar Akunuri, Joseph M Salvino, Fidele Ntie-KangDesign, synthesis, and biochemical and computational screening of novel oxindole derivatives as inhibitors of Aurora A kinase and SARS-CoV-2 spike/host ACE2 interaction. Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents 33 (4) (2024)
- Donatus Bekindaka Eni, Joel A Cassel, Cyril T Namba-Nzanguim, Conrad V Simoben, Ian Tietjen, Ravikumar Akunuri, Joseph M Salvino, Fidele Ntie-KangDesign, synthesis, and biochemical and computational screening of novel oxindole derivatives as inhibitors of Aurora A kinase and SARS-CoV-2 spike/host ACE2 interaction. Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents 33 (4) (2024)
- Donatus Bekindaka Eni, Joel A Cassel, Cyril T Namba-Nzanguim, Conrad V Simoben, Ian Tietjen, Ravikumar Akunuri, Joseph M Salvino, Fidele Ntie-KangDesign, synthesis, and biochemical and computational screening of novel oxindole derivatives as inhibitors of Aurora A kinase and SARS-CoV-2 spike/host ACE2 interaction. Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents 33 (4) (2024)
- Donatus Bekindaka Eni, Joel A Cassel, Cyril T Namba-Nzanguim, Conrad V Simoben, Ian Tietjen, Ravikumar Akunuri, Joseph M Salvino, Fidele Ntie-KangDesign, synthesis, and biochemical and computational screening of novel oxindole derivatives as inhibitors of Aurora A kinase and SARS-CoV-2 spike/host ACE2 interaction. Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents 33 (4) (2024)